शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEJohnson Pharmacare Ltd· Commercial Services & SuppliesHighNeutral
Announced Wed, 23 Jul, 2025 · 13:56 IST

PFA

Pat NegativeRevenue DeclineResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.3%Reaction day
₹0.87
prior close
₹0.86
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-2.0% vs market
Diversified Commercial Services peers, median of 69sector-0.3%-2.0% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.0 pts less than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-1.2
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.3-0.2-2.0-0.3-2.0
Next day
-2.3-0.5-1.8-0.4-1.9
2d
-4.6-2.4-2.2-2.2-2.4
3d
-3.4-3.6+0.2-3.4-0.1
4d
-3.4-2.2-1.3-3.0-0.4
5d
-3.4-1.9-1.6-2.9-0.6
1w
-5.7-4.1-1.6-4.0-1.8
15d
-11.5-5.2-6.3-3.5-7.9
1m
-10.3-3.9-6.4-4.4-5.9
2m
-12.6-2.3-10.4-3.4-9.3
3m
-27.6-3.4-24.2-4.1-23.5
UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 69Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Johnson Pharmacare Limited (formerly Sun and Shine Worldwide Limited) reported zero revenue from operations for Q1 FY26, same as Q1 FY25. Total expenses stood at Rs. 5.34 lacs vs Rs. 3.99 lacs in the year-ago quarter, driven mainly by employee costs (Rs. 0.30 lac) and other expenses (Rs. 5.04 lacs). The company posted a net loss of Rs. 5.34 lacs for the quarter, slightly wider than the Rs. 3.99 lac loss in Q1 FY25. There were no exceptional items this quarter, compared to Rs. 17.16 lacs in the prior-year period. Full-year FY25 ended with a net loss of Rs. 58.38 lacs. The statutory auditor (Rishi Sekhri and Associates) issued an unmodified limited review report with no qualifications.

Likely market impact

The company continues to generate no operating revenue and is reporting persistent losses, suggesting limited business activity and potential going concern risks for shareholders. The stock is likely illiquid and of speculative nature given the negligible scale of operations.